Esperion Therapeutics Inc (ESPR)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 18.82M | 24.33M | 25.79M | 33.97M | 32.25M | 137.74M | 73.83M | 51.63M |
営業利益 | -42.51M | -48.61M | -37.06M | -27.53M | -42.37M | 72.27M | 2.58M | -16.03M |
税引前収入 | -55.49M | -61.72M | -49.94M | -41.25M | -56.34M | 61.02M | -61.93M | -29.52M |
純利益 | -55.49M | -61.72M | -49.94M | -41.25M | -56.34M | 61.02M | -61.93M | -29.52M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -41.16M | -47.33M | -35.4M | -26.26M | -41.29M | 75.05M | 5.03M | -14.44M |
EBITDA | -42.42M | -48.52M | -37.01M | -27.51M | -42.36M | 72.27M | 2.59M | -16M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 148.36M | 227.55M | 78.45M | 75.48M | 116.33M |
営業利益 | -76.15M | -168.98M | -204.59M | -93.1M | -121.4M | -226.73M | -179.5M | -155.56M |
税引前収入 | -74.98M | -166.99M | -201.81M | -97.17M | -143.55M | -269.11M | -233.66M | -209.25M |
純利益 | -74.98M | -166.99M | -201.81M | -97.17M | -143.55M | -269.11M | -233.66M | -209.25M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.324 | -6.348 | -7.523 | -3.534 | -5.143 | -4.28 | -3.133 | -1.84 |
EBIT | -77.2M | -169.29M | -204.41M | -92.75M | -121.4M | -222.76M | -176.85M | -150.27M |
EBITDA | -75.9M | -168.72M | -204.32M | -92.78M | -120.85M | -226.12M | -179M | -155.4M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約